Clinical Trials for Caribou Biosciences

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Caribou Biosciences

Clinical Trials (3)

NCT05722418
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
PHASE1Recruiting
50 participants
Started: Feb 6, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor16 locations
NCT05332054
Long-Term Follow-up Study
N/AEnrolling by invitation
150 participants
Started: Mar 16, 2022 · Completed: Dec 31, 2041
10 conditions1 sponsor30 locations
NCT04637763
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
PHASE1Recruiting
72 participants
Started: May 26, 2021 · Completed: Sep 30, 2025
7 conditions1 sponsor38 locations